Susan Jean Wallcraft
Direktor/Vorstandsmitglied bei Amnesty International Charity Ltd.
Aktive Positionen von Susan Jean Wallcraft
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Amnesty International Charity Ltd.
Amnesty International Charity Ltd. Miscellaneous Commercial ServicesCommercial Services Amnesty International Charity Ltd. was founded in 1986 and promotes and protects human rights. The non-profit company is based in London, UK. | Direktor/Vorstandsmitglied | 28.05.2017 | - |
Karriereverlauf von Susan Jean Wallcraft
Ehemalige bekannte Positionen von Susan Jean Wallcraft
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VERNALIS | Unternehmenssekretär | 25.01.2018 | 31.03.2019 |
Pfizer Consumer Healthcare (United Kingdom)
Pfizer Consumer Healthcare (United Kingdom) Drugstore ChainsRetail Trade Pfizer Consumer Healthcare Ltd. wholesales pharmaceutical goods. The company was established in 1913 and is headquartered in Berks, GB. | Direktor/Vorstandsmitglied | 04.03.2011 | 06.04.2011 |
Statistik
International
Vereinigtes Königreich | 4 |
Operativ
Director/Board Member | 2 |
Corporate Secretary | 1 |
Sektoral
Retail Trade | 2 |
Commercial Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Pfizer Consumer Healthcare (United Kingdom)
Pfizer Consumer Healthcare (United Kingdom) Drugstore ChainsRetail Trade Pfizer Consumer Healthcare Ltd. wholesales pharmaceutical goods. The company was established in 1913 and is headquartered in Berks, GB. | Retail Trade |
Amnesty International Charity Ltd.
Amnesty International Charity Ltd. Miscellaneous Commercial ServicesCommercial Services Amnesty International Charity Ltd. was founded in 1986 and promotes and protects human rights. The non-profit company is based in London, UK. | Commercial Services |
Ligand UK Ltd.
Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1988 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Susan Jean Wallcraft
- Erfahrung